Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/1995
08/22/1995US5444057 For treating bacterial infections
08/22/1995US5444052 Synergistic mixture with a glycerol ether
08/22/1995US5444051 Erythromycin compounds
08/22/1995US5444044 Synthetic polypeptides as inhibitors of HIV-1
08/22/1995US5444043 Cyclic depsipeptide non-steroidal antiinflammatory agent
08/22/1995US5443982 Continuous avian hepatocellular carcinoma cell line containing infectious laryngotracheitis virus
08/22/1995US5443976 Making antivenoms of rattlesnakes by attaching two whole venoms having antibody binding capacity to insoluble aldehyde activated agarose substrate by covelentyl bonding
08/22/1995US5443972 Fermentation of Streptomyces
08/22/1995US5443828 AIDS vaccine
08/22/1995CA2012013C Antitumor antibiotic bmy-41339
08/17/1995WO1995021915A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995WO1995021912A1 Non-pathogenic strains of hiv-1
08/17/1995WO1995021627A1 Active immunization using a siderophore receptor protein
08/17/1995WO1995021625A1 Prolactin as a vaccine adjuvant
08/17/1995WO1995021601A2 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
08/17/1995WO1995021528A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
08/17/1995WO1995007994A3 Recombinant alphavirus vectors
08/17/1995CA2183260A1 Prolactin as a vaccine adjuvant
08/17/1995CA2183154A1 Non-pathogenic strains of hiv-1
08/17/1995CA2183066A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/16/1995EP0667353A1 Glycopeptide antibiotic derivatives
08/16/1995EP0667351A1 Compound uch9
08/16/1995EP0667348A1 Process for the preparation of nevirapine
08/16/1995EP0667346A2 Azole antifungal agents, process for the preparation there of and intermediates
08/16/1995EP0667161A1 Delayed release dosage form comprising clindamycin palmitate
08/16/1995EP0666914A1 Novel p-selectin ligand protein
08/16/1995EP0666862A1 6-(substituted methylene) penems and intermediates
08/16/1995EP0666861A1 Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
08/16/1995EP0666853A1 Antimicrobial 5-hydrazino-quinolone derivatives
08/16/1995EP0666850A1 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8a-g(b))-6-ISOQUINOLINEAMINE DERIVATIVES, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF.
08/16/1995EP0666843A1 Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors
08/16/1995EP0666759A1 Preparation for therapeutic and especially prophylactic treatment of digestive tract disorders
08/16/1995EP0666755A1 Inhibitiion of retrovirus infection
08/16/1995EP0666751A1 Hepatitis a virus vaccines
08/16/1995EP0666749A1 ENANTIOMERICALLY PURE beta-D-DIOXOLANE NUCLEOSIDES WITH SELECTIVE ANTI-HEPATITIS B VIRUS ACTIVITY
08/16/1995EP0666744A1 Use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection
08/16/1995EP0666743A1 Soluble calcium lactate/quindonecarboxylic acids on naphthydrinecarboxylic acids complexes as non-irritating parenteral forms
08/16/1995EP0666742A1 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-retroviral agents and anti-tumor agents
08/16/1995EP0655920A4 Astragalus polysaccharide immunomodulators.
08/16/1995EP0532525B1 New protein-polycation conjugates
08/16/1995EP0472531B1 Proanthocyanidol-based composition and its pharmacological application
08/16/1995CN1106980A Anti-aids immunomodulator complex
08/16/1995CN1106695A Inhibitor of HIV activity
08/15/1995US5442070 Chemical intermediates for antimicrobial compounds
08/15/1995US5442059 Antibiotics for mammalian and veterninary diseases
08/15/1995US5442055 Azetidinone compound and process for preparation thereof
08/15/1995US5441983 Treatment of infection by enveloped virus with calix(N)arene compounds
08/15/1995US5441976 Immunostimulants
08/15/1995US5441949 Therapy for bacteria infections
08/15/1995US5441940 Process for the preparation of water soluble primycin and its components and pharmaceutical compositions containing them
08/15/1995US5441939 3"-desmethoxy derivatives of erythromycin and azithromycin
08/15/1995CA1336691C Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects
08/15/1995CA1336684C Dsrna-based prevention of viral escape
08/15/1995CA1336683C Diagnosis and treatment of double-stranded rna deficiency states
08/15/1995CA1336680C Method and compositions for the treatment and prevention of septic shock
08/10/1995WO1995021256A1 Msrv1 virus and msrv2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same
08/10/1995WO1995021189A1 Hepatitis b vaccine
08/10/1995WO1995021186A1 Macrocyclic difluorostatone derivatives useful as antiviral agents
08/10/1995WO1995021184A1 Substituted purines and oligonucleotide cross-linking
08/10/1995WO1995021164A1 Intermediate and process for making
08/10/1995WO1995021162A1 Process for making hiv protease inhibitors
08/10/1995WO1995020978A1 Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels
08/10/1995WO1995020968A1 Prophylatic for domestic animal mastitis
08/10/1995WO1995020965A1 Hiv protease inhibitors and intermediates
08/10/1995WO1995020962A1 Protease inhibitors
08/10/1995WO1995020961A1 Vitamin e and derivatives prevent damage in red cells sterilized by phthalocyanines and light
08/10/1995WO1995020959A1 Use of sialic acid or antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
08/10/1995CA2182723A1 The use of anti-tnf antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6
08/10/1995CA2182375A1 Hepatitis b vaccine
08/10/1995CA2182192A1 Protease inhibitors
08/10/1995CA2182090A1 Hiv protease inhibitors and intermediates
08/10/1995CA2180947A1 Process for making hiv protease inhibitors
08/10/1995CA2180860A1 Intermediate and process for making
08/09/1995EP0666317A2 Antisense oligonucleotides against HSV-1 and their preparation
08/09/1995EP0666269A2 Nucleoside derivatives and their use as medicaments
08/09/1995EP0666077A1 Anti-mrsa composition
08/09/1995EP0665847A1 Cephem compounds, and their pharmaceutical compositions
08/09/1995EP0665754A1 Antimicrobial peptides
08/09/1995EP0665752A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
08/09/1995EP0665729A1 Biocompatible polymers containing diagnostic or therapeutic moieties
08/09/1995EP0348446B1 Antiviral antitumor antimetastatic immune system enhancing nucleosides and nucleotides
08/09/1995CN1106412A Derivatives of 1-(2-fluorocyclopropyl)-quinolonecarboxylic acid and 1-(2-fluorocyclopropyl)-naphthyridone carboxylic acid
08/09/1995CN1106411A Novel cephalosporin antibiotics and processes for preparation thereof
08/09/1995CN1106408A 2-beta-alkenyl penam sulfones as beta-lactamase inhibitors 2-beta-alkenyl-penam-sulfonverbindungen als beta-lactamase-hemmer
08/09/1995CN1106403A 3-hydroxy-4-hydroxymethyl-2-methylenecyclopentyl purines and pyrimidines
08/09/1995CN1106390A Azole compounds, their production and use
08/09/1995CN1106389A 氨基喹啉衍生物 Aminoquinoline derivative
08/09/1995CN1106299A Live in ovo vaccine
08/09/1995CN1106296A Nutritional Supplement
08/08/1995US5440040 Drug for Aids therapy; viricides
08/08/1995US5439904 2-spiro(2'-spirocycloalkyl)cyclopropyl cephalosporin sulfones as antiinflammatory and antigenerative agents
08/08/1995US5439892 Dextrin sulfates as anti HIV-1 agents and composition thereof
08/08/1995US5439890 Erythromycin derivatives
08/08/1995US5439889 Erythromycin derivatives
08/08/1995US5439810 Manipulation of gene copy number in bordetella
08/08/1995US5439809 Non-infectious HIV particles lacking long terminal repeats
08/08/1995US5439808 Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
08/08/1995US5439685 Vaginal tampon containing cholic acid or salt as microbiocide, dimethylsiloxane as protective film forming agent, hydroxy-propylmethyl cellulose as thickener, benzalkonium chloride and nonoxynol 9 as spermicidal agents
08/08/1995US5439680 Cell-associated glucosyltransferase, an antibody thereto, and a dental caries prophylactic composition containing said antibody as an effective component
08/08/1995CA1336578C Antiviral composition containing a hybrid _-interferon and its use
1 ... 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 ... 1798